Abstract
COVID-19 caused by SARS-CoV-2 is seriously endangering the health of all human beings. There is an urgent need for drugs that can inhibit the replication and propagation of the virus. Traditional macromolecular drugs have long discovery and development cycles and high experimental costs, which can't give rapid response to new viruses. Through computational protein design method, scientists have designed binder proteins with high affinity for the RBD of SARS-CoV-2 spike protein which can effectively inhibit virus replication. However, traditional computational protein design methods rely heavily on human experience and domain knowledge of protein design, and the protein design workflow is too complicated to be widely accepted and used in academia and industry. Based on previous work in the field of deep neural network protein structure prediction and protein design, we developed a novel protein outpainting method that can generate the remaining part of the protein based on a given hot spot motif and complete the entire protein. This method can generate stable protein scaffold which can support the functional hot spot motif, resulting in a protein with excellent thermal stability and developability. We tested this method in a drug discovery project with the aim of designing new SARS-CoV-2 inhibitors. Several proteins are obtained which are predicted to be stable and may have high affinity for the RBD of the SARS-CoV-2 spike protein. Although they have not been verified by wet-lab experiments, we believe that these proteins have great potential to be developed into effective drugs for the treatment of COVID-19. The protein outpainting algorithm proposed in this paper has great advantages over traditional protein design methods. It can be applied to many fields that require the design of functional proteins, such as protein drug design, enzyme de novo design, vaccine design, etc. The method will play an important role in reducing the cost of experiments, shortening the research and development period, and improving the successful rate of biological research and development.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.